476 related articles for article (PubMed ID: 33928620)
1. What if COVID-19 affects the child: which weapons and how to use them.
Anedda L; Bianchini L; Cuzzolin L; Finco G; Fanos V; Marcialis MA
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3325-3337. PubMed ID: 33928620
[TBL] [Abstract][Full Text] [Related]
2. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
Panovska-Stavridis I; Ridova N; Stojanoska T; Demiri I; Stevanovic M; Stojanovska S; Ristevska T; Dimkovski A; Filipce V; Dimovski A; Grozdanova A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):5-18. PubMed ID: 33894123
[TBL] [Abstract][Full Text] [Related]
3. Treatment of SARS-CoV-2: How far have we reached?
Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A
Drug Discov Ther; 2020 May; 14(2):67-72. PubMed ID: 32336723
[TBL] [Abstract][Full Text] [Related]
4. Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
Miller-Handley H; Luckett K; Govil A
Adv Chronic Kidney Dis; 2020 Sep; 27(5):434-441. PubMed ID: 33308510
[TBL] [Abstract][Full Text] [Related]
5. Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Yadav AK; Wen S; Xu X; Yu L
Ann Palliat Med; 2021 Jan; 10(1):707-720. PubMed ID: 33440983
[TBL] [Abstract][Full Text] [Related]
6. Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials.
Abrams-Downey A; Saabiye J; Vidaurrazaga M
Eur Urol Focus; 2020 Sep; 6(5):1028-1031. PubMed ID: 32563675
[No Abstract] [Full Text] [Related]
7. Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH).
Díaz E; Amézaga Menéndez R; Vidal Cortés P; Escapa MG; Suberviola B; Serrano Lázaro A; Marcos Neira P; Quintana Díaz M; Catalán González M
Med Intensiva (Engl Ed); 2021 Mar; 45(2):104-121. PubMed ID: 32854988
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and Its Implications for Thrombosis and Anticoagulation.
Berkman SA; Tapson VF
Semin Respir Crit Care Med; 2021 Apr; 42(2):316-326. PubMed ID: 33548929
[TBL] [Abstract][Full Text] [Related]
9. Possible treatment and strategies for COVID-19: review and assessment.
Trivedi N; Verma A; Kumar D
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12593-12608. PubMed ID: 33336780
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
[TBL] [Abstract][Full Text] [Related]
11. Treatment of COVID-19: a review of current and prospective pharmacotherapies.
Quek E; Tahir H; Kumar P; Hastings R; Jha R
Br J Hosp Med (Lond); 2021 Mar; 82(3):1-9. PubMed ID: 33792391
[TBL] [Abstract][Full Text] [Related]
12. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
13. [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.].
Cruciani F; Amato L; De Crescenzo F; Mitrova Z; Saulle R; Vecchi S; Davoli M
Recenti Prog Med; 2021 Mar; 112(3):195-206. PubMed ID: 33687358
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis.
Wang M; Wu T; Zuo Z; You Y; Yang X; Pan L; Hu Y; Luo X; Jiang L; Xia Z; Deng M
BMJ Support Palliat Care; 2021 Mar; 11(1):45-52. PubMed ID: 32958501
[TBL] [Abstract][Full Text] [Related]
15. Psychopharmacology of COVID-19.
Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
[TBL] [Abstract][Full Text] [Related]
16. Potential strategies for combating COVID-19.
Shamim S; Khan M; Kharaba ZJ; Ijaz M; Murtaza G
Arch Virol; 2020 Nov; 165(11):2419-2438. PubMed ID: 32778950
[TBL] [Abstract][Full Text] [Related]
17. Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children.
Miao H; Li H; Yao Y; Wu M; Lu C; Wang J; Tian M; Li Y; Luo P; Gu J; Yuan B; Wang S; Zhao X; Gan W; Zhao D
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2211-2223. PubMed ID: 32761481
[TBL] [Abstract][Full Text] [Related]
18. Some drugs for COVID-19.
Med Lett Drugs Ther; 2020 Apr; 62(1595):49-50. PubMed ID: 32324177
[No Abstract] [Full Text] [Related]
19. Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series.
Herth FJF; Sakoulas G; Haddad F
Respiration; 2020; 99(12):1145-1153. PubMed ID: 33316806
[TBL] [Abstract][Full Text] [Related]
20. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
